Evidence·Distribution / Barrier
ReportedPlasma protein binding evidence
ATLXM0045326
A single reference-linked measurement — its measured value, assay/model context, and interpretation layer kept separate.
Stack
ATLXM0045326
A single reference-linked measurement — its measured value, assay/model context, and interpretation layer kept separate.
ATLXM0045326
About 50% of the administered dose is taken up by erythrocytes while about 34% is bound to lipoproteins. Prescribing information for Sandimmune states that 90% is mainly bound to lipoproteins.
This page treats the row as evidence attached to an endpoint and assay context. The layer describes how the row can be interpreted; it is not a safety or developability score by itself.
